Apexbio Technology A8505

PKI-402
A8505-10 10 mg
EUR 350
Description: PKI-402 is a selective, equipotent and ATP-competitive class I PI3K inhibitor (IC50= 1 nM, 7 nM, 16 nM and 14 nM for PI3K?, PI3K?, PI3K? and PI3K?, respectively.

Apexbio Reagents Laboratories manufactures the apexbio technology a8505 reagents distributed by Genprice. The Apexbio Technology A8505 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other Apexbio products are available in stock. Specificity: Apexbio Category: Technology Group: A8505

A8505 information

Phos-tag Biotin BTL-104
F4001-50 50 mg
EUR 1500

Phos-tag Acrylamide
F4002-10 10 mg
EUR 630

Phos-tag Acrylamide
F4002-5 5 mg
EUR 456

Phos-tag Acrylamide
F4002-50 50 mg
EUR 1500

Phos-tag Biotin BTL-105
F4004-10 10 mg
EUR 630

Phos-tag Biotin BTL-105
F4004-5 5 mg
EUR 456

Phos-tag Biotin BTL-105
F4004-50 50 mg
EUR 1500

4-Quinolone-3-Carboxamide Furan CB2 Agonist
C3511-10 10 mg
EUR 440
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

4-Quinolone-3-Carboxamide Furan CB2 Agonist
C3511-25 25 mg
EUR 902
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

4-Quinolone-3-Carboxamide Furan CB2 Agonist
C3511-5 5 mg
EUR 270
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

KT182
C3516-10 10 mg
EUR 241
Description: IC50: < 5 nMKT182 is an ABHD6 inhibitor.

KT182
C3516-5 5 mg
EUR 154
Description: IC50: < 5 nMKT182 is an ABHD6 inhibitor.

KT203
C3518-10 10 mg
EUR 241
Description: IC50: < 5 nMKT203 is an ABHD6 inhibitor. ABHD6, a unique and highly conserved enzyme in mammals, is prominently expressed in brain, liver, kidney, and brown adipose tissue based on global gene expression analysis and activitybased protein profiling (ABPP).

KT203
C3518-5 5 mg
EUR 154
Description: IC50: < 5 nMKT203 is an ABHD6 inhibitor. ABHD6, a unique and highly conserved enzyme in mammals, is prominently expressed in brain, liver, kidney, and brown adipose tissue based on global gene expression analysis and activitybased protein profiling (ABPP).

Arylquin 1
C3520-10 10 mg
EUR 258
Description: Arylquin 1 is a potent secretagogue of the tumor suppressor protein prostate apoptosis response-4 (Par-4).Par-4 is ubiquitously expressed in normal cells and tissues, but it is inactivated, downregulated or mutated in several types of cancers.

Arylquin 1
C3520-5 5 mg
EUR 171
Description: Arylquin 1 is a potent secretagogue of the tumor suppressor protein prostate apoptosis response-4 (Par-4).Par-4 is ubiquitously expressed in normal cells and tissues, but it is inactivated, downregulated or mutated in several types of cancers.

Hispidin
C3523-1 1 mg
EUR 144
Description: IC50: 2 ?MHispidin is a protein kinase C? inhibitor.Protein Kinase C (PKC), a serine/threonine kinase, is activated by signal transduction pathways producing DAG from phosphatidylinositol diphosphate and phosphatidylcholine via the action of various activated phospholipases.